Adial Pharmaceuticals (ADIL) Earnings Date & Reports

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ADIL is expected to report earnings to fall 71.84% to -41 cents per share on November 18

Adial Pharmaceuticals ADIL Stock Earnings Reports

Q3'26

Est.

$-0.42

Q1'26

Missed

by $1.29

Q4'25

Missed

by $1.43

Q3'25

Beat

by $0.31

Q2'25

Beat

by $0.21

The last earnings report on May 11 showed earnings per share of -148 cents, missing the estimate of -18 cents. With 44.67K shares outstanding, the current market capitalization sits at 16.32M.

View a ticker or compare two or three

ADIL

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days